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Summary
We have isolated T cell receptor (TCR) cDNAs from fluorescein (FL)-specific human T cell
clones (unfF1.), and transferred them to TCR f- Jurkat cells in order to study direct FLbinding
to the TCR. Using either FLconjugated polymers (FIrpolymer) or FIrsubstituted Sepharose
beads, we are able to demonstrate the direct binding of antigen to the T cell surface, and the
functional activation of the T cell transfectants. We present evidence against the involvement
ofmajor histocompatibility complex (MHC) molecules or antigen presentation in the interaction
of FL with the ciFLOFL transfectants. Additionally, we have examined the effect of ring
substitutions on the FL molecule as well as specific alterations of substituents attached to the
5' position, and we have found that all of them interfere with the functional recognition of
the a'FLOFL TCR. These experiments demonstrate that TCRs like antibodies have intrinsic
affinities for antigen, even without the involvement of MHC molecules.
M
olecular (reviewed in references 1 and 2) and cellular
(3-7) studies have identified the TCR for antigen as
a 90 kD a/f heterodimer on the T cell surface. The primary
function of TCRs is in the recognition of antigen in a com-
plex process that involves gene products ofthe MHC on APC
(8, 9). An important function of these MHC molecules is
to bind and present peptide fragments of protein antigens
for recognition by TCR. Defined peptides which represent
appropriate epitopes in foreign antigens will selectively bind
particular MHC molecules (10, 11). These peptides, when
presented by APC, will activate T cell clones (12) or trans-
fectants expressing TCRs ofthose clones in an antigen specific
and MHC-restricted fashion (13, 14). MHC molecules also
interact with CD4 (class 11 MHC) or CD8 (class I MHC)
cell-surface receptors on T cells in a manner which promotes
adhesion of the interacting cells and signal transduction
(15-18) . Transfection of antigen specific and MHC-restricted
TCRs into host cells of irrelevant specificity results in the
transfer of specificity for both MHC and antigen (19-21).
These results demonstrate that the TCR is the only mole-
cule necessary to establish antigen specificity and to confer
MHC restriction on a T cell.
There are few reports which demonstrate that antigen can
interact with TCR in a manner that is independent of MHC
(22-25). A novel series of murine (26) and human (27) T
cells which recognize the hapten fluorescein (FL)t were
generated to determine if the TCR has the intrinsic capacity
to bind antigen independent of MHC and accessory cells.
These clones were shown to interact with polymers substituted
with multiple FL molecules independently of accessory cells.
Several of the human FLspecific T cell clones can be acti-
vated to secrete IL-2 by incubation with Sepharose beads
conjugated with FLisothiocyanate (FITC; reference 27).
Significantly, solubilized forms ofthe surface TCR from these
clones specifically bound to FITC-substituted Sepharose
beads in affinity chromatography experiments (27). How-
ever, whether antigen recognition and functional cellular adhe-
sion of these clones couldoccur in an absolutely MHC inde-
pendent fashion was unclear. To address this issue, a transfection
model usinga functional T cell tumor with the TCRs from
the FLspecific T cell clones was developed to study the di-
rect binding of antigen to the TCR in the absence of APC
I Abbreviation used in this paper: FL, fluorescein.
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cellular transfection system which demonstrate that in this
system the TCR can engage the hapten FL under defined
circumstanceswithout MHCinteraction. In addition, we have
been able to define several parameters of the TCR's ability
to recognizethe FL molecule by examiningthe effect ofchem-
ical substitution on the FL ring system in a direct binding
and activation assay with transfected cells. This system may
be useful in theeventual determination of thepreciseantigen
binding site of a TCR.
Materials and Methods
CellLinesandFLPolytners.
￿
Thecell lines shownin Table 2were
propagated in RPMI-1640QRH Biosciences, Lenexa,KS)with the
standard additions which include glutamine, Pen-Strep, and 10%
FCS (JRH Biosciences). Transfectants were routinely grown in
RPMI-1640 OR Scientific) medium containing Hygromycin B
(Sigma Chemical Co., St. Louis, MO)at 0.5 mg/mL and/or G-418
(Gibco Laboratories, Grand Island, NY) at 0.5 mg/mL. CTLIL2
cells (American Type Culture Collection, Rockville, MI)) were
grownin RPMI-1640as describedabovewith theaddedsupplemen-
tation of 50 uM 2-ME and 10 u/mL rIIL2 (Cetus Corp., Emery-
ville, CA).
The properties of the FL-Polymers used in this publication are
summarized in Table 3 below. The preparation of FLconjugated
polyacrylamide, dextran, or Ficoll polymers has been previously
described in detail (26, 28, 29).
cDNA Cloning.
￿
T cell clones RFL 3.8 and 3.51 were stimu-
latedby FITC as previously described(27), and grown to adensity
of 106 cells/mL. Poly A* RNA was obtained by standard methods
after2xbindingto OligodT Cellulose(T7, CollaborativeResearch,
Waltham, MA). 5,ug of the poly A` RNA was used in the first
strand synthesis reaction, which was immediately followed by the
second strand synthesisprotocol ofGubler andHoffman(30). The
double stranded cDNA was made blunt ended by T4 DNA Poly-
merase, Eco RI linkers were attached after methylation by Eco RI
methylase, and thecDNA was size fractionated according to stan-
dard methods (31). 0.2 Ftg of cDNA was ligated to 1 Wg Eco RI
cleaved andpurified X gt-10arms (72) overnight at 12°C. Half of
the ligated DNA was packaged into X phage packaging extract
(Stratagene', La Jolla, CA) for 2 h at room temperature, and it
was inactivated by the addition of 0.5 mL TM (10 mM Tris-HCI,
pH 7.5 and 10 MM MgCl2) and 10 p.L chloroform. The phage
wastitrated on both permissive (HFL) andrestrictive (C600) strains
of bacteria, and a library of 1.25 x 106 pfu was obtained. The
cDNA libraryfrom RFL3.8 and3.51 were plated on square dishes
(24.5 cm x 24.5 cm x 2 cm) at adensity of 105 phage/plate. The
nitrocellulose lifts were screened usingeither the humanTCRC/3
gene segment(32) or theCa (33) gene segment.We found 1posi-
tive plaque per 5,000 pfu for both a anda cDNAs. The purified
EcoRI inserts from theA gt-10phageminipreparations were sub-
cloned into pCU12. ThecDN9s forboth the a and/3 chaingenes
were sequenced using a combination of gene-specific and MP18
sense and antisense primers. The amino acid sequence of all four
chains is presented in Fig. 1 F, together with the 30% conserved
sequences accumulated from 26 TCR cDNAs (34).
Northern and Southern Analysis.
￿
Thevariable segments of each
of the a and 0 cloned TCR cDNAs were subcloned, and used
as probes forboth Northern and Southern hybridization. cDNA
fragments from theDP, DO, andDR /3 genes were cut out from
pBR322, and purified over 1.2% agarose gel (obtained from L.
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Gadulis, and B. Wallace, HLALaboratory oftheCity ofHope Med-
ical Center). 10 p.g ofcellular DNA was digested with restriction
enzymes as indicated, andelectrophoresed on 1% agarose gels in
TBE(pH8.3)buffer (35). RNA samples (30,ug) were electropho-
resedon 1-1.5% agarose gels containing formaldehyde usingMOPS
(pH 7.5)as a runningbuffer (35). Transferswere accomplished by
capillary action of 20x SSC (pH 7.5) buffer onto nitrocellulose
sheets (BA85; Schleicher & Schuell, Keene, NH). The nitrocellu-
lose sheets were visualized by long wavelength UV light to assess
the evenness of the transfer of ethidium bromide stained nucleic
acids. The sheets were then further processed according to stan-
dard methods (35), and after 12 h of pre-hybridization, 5 x 105
cpm of denaturedprobe ("P-labeled) was added to thebag in hy-
bridization buffer containing 10% dextran-sulphate. After 12-14
hofhybridization, theblotswere washed using SSCas lowas 0.5 x,
andputup to film for timesrangingfrom 12 hto 5 dusingCronex
Lightning Plus Screens (Dupont).
cDNA Transfection in Eukaryotic Expression Vectors.
￿
To express
TCRcDNAs, we inserted them into expression vectors which in-
cluded theEBV virusOriP gene segment(36).Thevectors shown
in Fig. 1 G replicate as episomes in primate cells (37). The ability
to replicate dependson theinteraction of theEBNA 1protein with
OriP gene segment on theepisome (38). The CMVI-Epromoter
(kindly givenby Drs. Pandeand-Zaia, City of Hope MedicalCenter)
was cloned into the polylinker of both the p266.1 and p220.2
plasmids (kindly givenby Dr. W. Sugden, McCardle Laboratory)
to obtain high expression in human cell lines. The a and R chain
TCRs were cloned into p266.1 and p220.2 respectively, and the
junctional sequences determined (data not shown). The correct
orientation of theTCRcDNA containing vectorwasused in trans-
£ection.
Electroporation wascarried outusingamodification of aproce-
dure developed forhuman PBL andT cells (39). Briefly, cells were
split the night before transfection to a density of 0.3-0.4 x
106/mL. The following day cells were concentrated to 2 x 10'
cells/mL in RPMI-1640containing 10% FCS (completemedium),
and0.4 ml,were suspended in an electroporation cuvette together
with plasmid DNA at 100 hg/mL. The suspendedcells were in-
cubated on icefor 10; and then 1 pulseofelectroporationwascar-
ried out at 200-250V and 800-960Farad (BRL Cell-Porator). The
shocked cells were left on ice for an additional 10, then pipetted
and washed in complete medium. After2 d ofrecovery, the living
cells were separated by centrifugation through Ficoll and plated
in 96-well plates in Hygromycin B (0.5 mg/mL) or Hygromycin
B + G-418 (0.4 mg/mL + 0.5 mg/mL) to select for transfectants.
Typically, we found a frequency of 1 in 10`4 transfectants using
this procedure. Positive clones were identified initially by growth
in selection medium, and then expanded for FACS and Northern
analysis.
FACS Analysis.
￿
We examined 50 clones containing either the
RFL3 .8 or RFL.3.510 chainby FACS usingamABagainst CD3
(RW2-8C8; reference40) and staining with an FITC conjugated
goat anti-mouse secondary antibody (CappelLaboratories, Durham,
NC). Thecell staining procedurewas according to Silicianoet al.
(27), and propidium iodide (PI, 1 Rg/mL) was added to enable
exclusionofdead cells. Cells were analyzed on aBecton-Dickinson
FACS IV equipped with dual lasers (argon and UV). Both 90°
light scatter and the fluorescence channel (510 nM) were used to
gate the single cell population that wasfree of PI. The representa-
tive plots shown in Fig. 2 were obtained from analysis of 2 x 104
cells. Fluorescent microspheres were used to correct changesin am-
plitude in thefluorescence channel when comparing samples ana-
lyzed on different days. In general, the expression of the RFL3 .80 chain clones is 4-5 x greater than from the RFL3.51 /3 chain
in combination with the endogenousJurkat a chain (unpublished
data). However, Northern analysis ofa series of RNA samples from
the FACS analyzed clones did not reveal any significant difference
in the RNA expression (unpublished data). Others have found a
difference in TCR pairing ability between chains when the RNA
levels were similar (41).
In the case of the FIrPolymers, 106 cells to be analyzed were
washed twice in WM (HBSS containing 2% newborn calf serum
(1RH Biosciences), 10 mM Hepes (pH 7.4), 0.1% glucose, and
Penn-Strep]. The various FLPolymers were added to the cells in
50 P,L of the same buffer at a final concentration of 30 Ag/mL.
The cells were incubated in an ice bath for 30, then washed twice
in WM, and finally resuspended in 0.5 mL of WM containing
propidium iodide at 1 P,g/mL. The samples were kept ice cold until
analysis, typically in <2 h, otherwise the background staining would
rise dramatically. As with the antibody analysis, 2 x 10' cells were
analyzed per profile.
Cell sorting was accomplished with the aid of a Cicero analysis
system (Cytomation) on the FACS IV, and using standard tech-
niques ofcell preparation using azide-free medium. The brightest
5% ofcells were collected, expanded, and resorted to obtain a rela-
tively homogeneous population (see Fig. 2).
Cell Activation Assays. 0.6 x 106 cells to be treated with
agents (FLPolymer, etc.) were washed twice to remove antibiotics,
and resuspended in one well of a 24 well plate (Falcon) with 0.6
mL normal growth medium. The cells were incubated with the
agents for 24 h, and the supernatants collected by centrifugation
and stored at 4°C. FIrPolymers were added at 1 hg/mL with or
without 1 or 10 ng/mL PMA. Sepharose beads in a volume of 20
IAL (determined to be saturating by titration) were added to the
cells to be stimulated for 24 h. FIrCad was added as dilutions of
a dimethylformamide stock solution of 100 mM.
CTLL2 cells are cultured in 4U/mL recombinant 11,2 (Cetus
Corp.), and every 3-4 days they are restimulated with fresh IL2.
The cells to be tested are washed four times, and resuspended in
growth medium containing 50 g.M mercaptoethanol. 10" CTLL
were cultured in 100,uL medium in 96-well plates (NUNC) with
dilutions of 11,2 containing supernatants up to 50%, or a series
ofrIL2 dilutions,0.5 or 5 ng/mL PMA, or medium without addi-
tions. Each supernatant was tested in triplicate, and each experi-
ment was repeated twice or more. The data presented is an average
of all the experimental determinations for each point, with no sep-
arate determination having a standard error of >20% from the
mean.
Preparation ofSepharose Beads Substituted with FL Derivatives.
￿
We
followed the techniques described in (27), except for the following
modifications. 0.5 gram of CNBr Activated Sepharose 4B (Phar-
macia) was washed according to the manufacturer, and reacted with
a 100x excess of 1,6 diaminohexane in 0.1 M NaHC03 (pH 8.3)
for 2 hours, then washed again 2 x with coupling buffer. Either
a 1 or 8 mM solution of FITC or X-isothiocyanate was reacted
with the beads in 0.1 M borate buffer for 60' at 37°C. Alterna-
tively, when the FL derivative was in the amine form, it was directly
reacted with the Sepharosebeads without the previous spacer coup-
ling. The ligand was washed away, and the beads were neutralized
according to the manufacturer. Ethanolamine was reacted directly
with the Sepharose beads, and they were neutralized. The beads
were stored at 4'C under foil in PBS. Each batch of derivatized
bead was adjusted in concentration to 2 x 106 beads/mL. All of
the beads are greater in size than 50 P,M. The FL derivatives con-
taining primary amines were all obtained from Molecular Probes
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(Eugene, Oregon), while some of the isothiocyanate derivatives
were also obtained from Sigma Chemical Co.
Results
Cloning and Characterization of the uFAL f CRs.
￿
As a
first step in understanding the structural interactions between
FL and the TCR, we cloned the TCR ot and 0 chains from
cDNA libraries constructed from two human T cell clones
referred to as RFL 3.8 (CD4') and RFL 3.51 (CD8', Fig.
1 A-F and reference 27). We made V-J segment probes from
each ofthe 4 cDNAs, and hybridized them to various genomic
DNAs (Fig. 1 A-D) . Each of the 4 VJ segment probes hy-
bridized to a cell-specific rearranged band in the appropriate
DNA sample. For instance, the RFL 3.8 a cDNA VJ seg-
ment hybridized to a 3.5 kb Eco RI and a 3.2 kb Hind III
fragment in DNA from clone RFL 3.8 and a related CD4'
FTrspecific T cell clone RFL 3.1 while DNAs from other
human T cell and non-T cell lines had hybridizable bands
at different positions (Fig. 1 A, compare lanes 1 and 2 versus
3-5 and lanes 6 and 7 versus lanes 8-10). Note, that Jurkat
DNA has deleted the V segment that encodes the FLspecific
V~ gene segment (Fig. 1 A, lanes 4 and 9). In each case,
when an FLspecific VJ probe was hybridized to various test
DNAs, only the expected cell line from which the VJ seg-
ment was originally cloned demonstrated rearrangement.
The human gene segments used in each of the 4 cDNAs
are shown in Table 1. The a chain from RFL3.8 contains
a V gene segment which is almost identical to Va17 (2),
while the J segment was identical to a previously identified
J segment termed F in the recent nomenclature of (2). Addi-
tionally, the /3 chain from RFL 3.8 uses a V gene segment
that is similar to other members of the Vo 13.2 family, al-
though there are significant (16/92) amino acid differences
(2). In the case of clone RFL 3.51, the a chain contains a
V segment that is similar to the Va2 family, while the J seg-
ment (L) has been previously identified(2) . The (3 chain from
RFL 3.51 uses a new member of the V,32 gene family that
we have designated 2.5. The sequence of each of the individual
chains is shown in Figure 1F. There is a striking similarity
Table 1 .
￿
Gene Segments Used by FL-speck T Cell Receptors
Clone Phenotype Specificity Chain V D J C
RFL 3 .8
￿
CD4+CD8- ￿FL-Class II
￿
ca
￿
17
￿
-
￿
F
￿
C~
/3 13.2 1 1.5 Col
RFL 3.51 CD4- CD8*
￿
FL-Class I
￿
a
￿
2.8
￿
-
￿
L
￿
Ca
/3 2.5 1 1.5 Col
Summary of the gene segments used in the formation ofthe TCR cDNAs
cloned from the FL-specific T cell clones shown on the left side of the
table (27). The symbols V,D,J, and C are defined in the legend to Fig.
1. CD4 and CD8 expression were determined from both antibody (27)
and Northern analysis (Fig. 1 E).TCR*FL CHAIN VARIABLE REGION SEQUENCES
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Figure 1.
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Cloning and analysis of aFL
V
￿
OFL TCRs. (A) Rearrangement of the vari-
able segment gene used in the assembly of
90
￿
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￿
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￿
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￿
FLspecific TCRs: Detection by variable
gene-specific probes. The V.17 gene seg-
SFSL. ITASQP. DSAVYFCA. . . . . SG. KLIMGTRISV.P
￿
304 CONSERVED
￿
ment from the T cell clone RFL3.8 was
QFSLHIMD.SQPGDSATYFCA-ASFSGNTPLVFGKGTRLSVIA
￿
RFL 3 .8
￿
labeled with random hexamers and CI-32P
YVSLLIRDSQPSDSATYLCAVNGVSDGQKLLFARGTMLKVEP
￿
RFL 3 .51
V
￿
I
￿
J
￿
[dCTPI using the Klenow enzyme. Ge-
nomic DNA samples from T cell clone
RFL3.1 (lanes 1 and 6), RFL3.8 (lanes 2
TCR 8FL CHAIN VARIABLE REGION SEQUENCES
￿
and 7) autologous EBV transformed cells
from (lanes 3 and 8), Jurkat T cells (lanes
4 and 9), and HeLa cells (lanes 5 and 10)
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or Hind III (lanes 6-10) and probed with
MSLGLLCCGVFSLLWAGPVNAGVTQTPKFRVLKTGQSMTLLCAQDMiHE-
￿
RFL 3 .8
￿
the Va17 gene segment. (B) The blot in
MLLLLLLLLLLLGPGSGL ;AVVSQHPSRVICKSGTSVKIECRSLDFQAT
￿
RFL 3 .51
￿
(A) was reprobed with the Vs132 gene .
p220.2/i0
confers NyfR
V
￿
segment from the T cell clone RFL3.8. (C)
The V~2.8 gene segment from the T cell
40
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RFL3.51 was labelled as described in (A). i
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i
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DNA from Jurkat (lanes 1, 4, and 8),
YMYWYRQDPGMGLRLIHYSVGEGTTAKG-QV-P-DGYNVSRLKKQNFLLG
￿
RFL 3 .8
￿
RFL3.8 (lanes 2, 5, and 8), and RFL3.51
TMFWYRQFPKKSIMLMATSN-EGSKATYEQGVEKDKFLINHASLTLSTLT
￿
RFL 3 .51
￿
(lanes 3, 6, and 9) was cut with Bam HI
V
￿
(lanes 1-3), Hind 111(4-6), or Xba I (lanes
7-9) and probed with the V,, 2.8 gene seg-
90
￿
100
￿
110
￿
ment. (D) The blot shown in (C) was
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￿
reprobed with the V~2.5 gene segment
LESAAPSQTSVYFCASRTATQPQHFGDGTRISIL
￿
RFL 3 .8
￿
from T cell clone RFL3.51. In each ofthe
VTSAHPEDSSFYICSARVPGEPQHFGDGTRISIL
￿
RFL 3 .51
￿
panels the arrow(s) point to the location
V -
￿
1
￿
D-J
￿
ofthe rearranged band. (E) Northern anal-
ysis ofthe RNA prepared from FIjspecific
T cell clones and theJurkat cell line. RNA
C7
￿
prepared from T cells such as RFL3.8 (lane
EBV BASED EXPRESSION PLASMIDS
￿
1, 6, and 7), RFL3.51 (lane 2, 4, and 9),
WHICH ARE MAINTAINED AS EPISOMES IN HUMAN CELLS
￿
RFL3.4 (lane 3), andJurkat (lane 5 and 8)
was hybridized with the indicated probes
from the T cell clones RFL 3.8 (Vq8 or
V08) and RFL 3.51 (V,,51 or V051) or
from the CD8 or CD4 genes (kindly
provided by D. Littman, University of
7%
1
￿
\~" o Qti \ ~~ t~ 1\
\Z, "
California at San Francisco). (F) Sequences
(Bam/NinAlII)
￿
I
￿
were obtained from cDNAs subcloned into p266,f/a
￿
EcoRI
￿
(NOW
￿
\~
￿
\
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EcoRI
￿
PUC12. Theprotein domains are signified
confers 6-4180
￿
as the letters L (leader peptide), V (Vari-
EBN 1A
￿
OriP
￿
CMV ¢chum
￿
TK 8"180
￿
pR
￿
able region), D (Diversity Region), and J
It
￿
TCR
￿
(Joining Region). The dashes give the best
alignment based upon the position of cys
1\
￿
\\
￿
~\
￿
teine residues. The 30% conserved sequence
0
￿
o
￿
a
￿
is from Kabat et al. (34). The placement
P
\~' N%`\
￿
0; \o°
￿
\
￿
\
￿
of periods indicates <30% sequence con-
~ \~ " t
￿
~° °N
￿
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￿
servation. (G) Vectors used to express the
0 ° \Z'°i'' _0\1.
￿
aFLPFL TCR cDNAs in T cells. The Cy-
So
￿
tomegalovirus Immediate-Early promoter- (NorI) I
￿
(/\
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￿
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￿
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of Hope Medical Center) was cloned as a _
￿
_
EBNA1
￿
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￿
CYY ochoin
￿
TK" Hy9R
￿
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￿
Hind III fragment, followed by the cloning
IE
￿
TCR
￿
of the TCR ot or /3 cDNAs.
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in both TCR ci cDNAs between as 67-74 shows similarity
where most TCRs are divergent. Finally, Northern analysis
further confirms the specificity of the V-J segments for the
individual T cell clones, as well as the absence of minor spe-
cies of contaminating TCR RNAs (Figure 1 E).
Transfection and FRCS Analysis.
￿
We subcloned both pairs
of FLspecific TCR cDNAs into a novel series of expression
vectors based upon the Epstein-Barr virus (EBV) (Figure 1
G). The expression ofthe EBNA I gene allows the OriP gene
segment to function as an origin of replication, and as a re-
sult the plasmids are maintained as episomes in human cells
(36). The vectors were introduced into the TCR /3 - mu-
tant ofJurkat, 31-13 (42) by electroporation (39). Single colo-
nies were selected and expanded in Hygromycin containing
medium, and analyzed by fluorescence activated cell sorting
(FRCS) to determine whether the introduction of a (3 TCR
cDNA had restored expression of surface CD3 expression (42,
43). Figure 2 shows that compared to the parental line Jurkat,
31-13 is negative for CD3. In contrast, the single transfec-
tants 3C11 or 42 (Table 2) which express (3p, TCR chains
from clones RFL 3.8 and RFL 3.51 respectively, have almost
completely restored surface CD3 expression. Subsequently,
we introduced the vector p266.1/a (Figure 1G) carrying the
UF, TCR chain of clone RFL 3.8 into the cell line 3C11 and
administered the dual selection of G-418 and hygromycin.
Surprisingly, we observed colonies within 1 week, at a fre-
quency 100 fold higher than in the initial transfection with
p220.1/0 (Figure 1 G). This may be the result of the already
established EBV plasmid supplying EBNA I in trans to the
incoming plasmid which has its own OriP site (37).
In order to determine if both the apL and ate, TCR chains
were being expressed, individual drug-resistant clones were
expanded, and subsamples were stained with the FITC con-
taining polyacrylamide polymer, FL79oPAnw (see Table 3 for
a description of the FLpolymers and Table 2 for the cell trans-
fectants) and analyzed by FACS (Fig. 2). Only cell lines such
as A5A6 (Table 2) which contain both the a and 0 TCR
chains from clone RFL 3.8 bound polymer, while the pa-
Table 2.
￿
Cell Line Properties
Cell line
￿
TCR chai
Jurkat (J77)
￿
aJ and (3J
31-13
￿
00
3C11N
￿
cap and OFL8
43N
￿
ai and OR8
ASA6
￿
aJ and aFL8 +
1C5
￿
aJ and aFL8 +
E3E4
￿
aJ and aFL8 +
42
￿
cxj and OFL51
E2
￿
aJ and aFL8 +
234
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31-13
Jurkot
aFL80FL 8
A5A6
051-42
Figure 2.
￿
FRCS profiles ofTcell lines usinganti-CD3 or the FI polymer.
(A) The cell lines listed on the right-hand side of the figure were first
treated (2 x 104) with either medium (background), OKT3 (CD3), or
FL90PA230o (FLPolymer) as described in Materials and Methods. The cells
were then reactedwith fluoresceinated and affinity-purified goat anti-mouse
2° antibody (Background and CD3). There was no secondary. reaction
with the cells stained with the F1,Polymer. A description of the cell lines
can be found in Table 2 and in the text.
rental line and other transfectants which contained just a OFL
chain were negative. The degree ofbinding of the FLPolymer
to the COLk cell lines is reduced, because there are two
types of TCR on the cell surface. One type is the functional
am8 0FL51
E2
Table 2 summarizes the properties of the cell lines used in this publication. Details of the derivation of the transfectant cell lines and their growth
conditions can be found in Materials and Methods.
k VL
s Selection conditions Reference
None Alcover et al. 1988
None Alcover et al. 1988
Hygromycin This paper
Hygromycin This paper
NFLS Hygromycin + G-418 This paper
00 Hygromycin + G-418 This paper
00 Hygromycin + G-418 This paper
Hygromycin This paper
OFL51 Hygromycin + G-418 This paperTechniques of analysis to determine average molecular weights of polymer preparations were done as previously described (26) . FL content of poly-
mers was measured as described in (27) .
Figure 3 .
￿
Proliferation assays using supernatants fromT cell lines acti-
vated byFI*polymer reagents . (A) Antibody and Calcium Ionophore stimu-
late 11,2 production inT cells. TheT cells indicated in the box were treated
with the reagents indicated on the bottom of (A) for 24 h as described
in MaterialsandMethods. 50% supernatants were incubated withCTLL
2 cells for a total of 24 h including a 6-h pulse with 3H-thymidine (1 p,Ci) .
The cells were harvested with the aid of a semi-automatic cell harvester
apparatus (Skatron Inc ., Sterling, VA) . The bars represent data collected
from at least two experiments with each treatment done in triplicate
(n - 6) with an SE of <20% . The cell lines are described in Table 2 .
(B) FLpolymer treatment ofT cell transfectants. The cell lines indicated
in theboxon the left of(B) were treatedwith the indicatedreagents (bottom)
as described in (A) . The FLpolymers FLD (FL,oooDex2soo), FLP (FL,ooo
PA25OO), or FLF (FL6sFic22o) are described in Table 3 .
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UFAL TCR, while the other is the mixed TCR containing
COL + a1 which is non-functional as is the case in the cell
line 3C11N (Fig . 2) . Our analysis of the TCRs from clone
RFL 3.51 has been hampered, because the /3 chain is unstably
expressed in transfected 31-.13 cells, so we are unable to test
whether the as heterodimer from RFL 3.51 binds FL . It
is clear in the cell lineswe tested that the ci or,6TCRcDNA
from RFL 3.8 alone or in combination with other TCR chains
does not confer FL binding (Fig. 2, compare clones 3C11
or E2 withA5A6) . Therefore, for cloneRFL 3.8, we assume
that both the ct and (3 TCR chains contribute to antigen
binding .
Stimulation ofIIr2 Secretion by FL .
￿
As reported previously,
FLPolymer binding to the T cell clone RFL 3.8 caused the
production of 1172 (27) . The transfection system presented
here allows us to determine unequivocally whether there is
a necessity for cellular presentation of the FLPolymer in order
to stimulate the transfectant to produceIL2 . Since the TCR
a1 (Table 2) reconstituted 31-13 cells make IL2 (41, 43), we
first determined whether the UFLOFL cell line would also
make IL2 (Fig. 3 A) when challenged with a mAB against
CD3 or with a combination of the calcium ionophore A23187
and PMA (44-46) . We used a different CIFLRFL cell line called
1C5 in this experiment (see Table 2 for a description of the
transfectant cell lines), and found that 1C5 and Jurkat cells
responded similarly to these stimuli . Subsequently, we in-
cubated the cells shown in Fig. 3 B with FLPolymers with
and withoutPMA for 24 h, and quantitated the IL2 produc-
tion by CTLL assay. Clearly, the FLPolymer in combination
with PMA specifically activates the cxFLRFL cell lines A5A6
andE3E4 (Table 2), although the FLPolymer without PMA
was not able to activate the CIFLOFL T cells to make IL-2 (Fig.
3 B) . Cell lines 3C11N and 31-13 did not respond to FL
Polymer, regardless of the polymer backbone (see Table 3) .
However 31-13 (Fig. 3 A) or 3C11N (data not shown) are
capable ofbeing activated to make IL-2when incubated with
calcium ionophore + PMA which bypasses the requirement
for triggering through the surface TCR (42) . These results
explicitly show that only the «FLOFL transfectants will re-
spond to FL-Polymers, whereas other T cells, although capable
ofmaking IL-2 (Figure 3A) are incapable offunctionally recog-
nizing the FL antigen .
Table 3. Properties
Designation
of FL-Polymers
Polymer backbone
Average mol wt
(x 10 -5 )
Antigen valence
(FL groups/molecule)
Epitope density
(mol FL/g polymer x 104)
FL,9oPA23oo Polyacrylamide 23.0 790 2.91
FL,oooPA25oo Polyacrylamide 25.0 1,000 2.50
FL95PA3w Polyacrylamide 3.0 95 3 .16
FL,oooDex25oo Dextran 25.0 1,000 2.50
FLoDex33o Dextran 3.3 110 3.00
FL65Fic22o Ficoll 2.2 65 3.38Inability to Detect MHC Class II Gene Expression in Trans-
fected Cells by Northern Analysis. The direct binding studies
described in the preceeding section showed that FIrPolymers
which bind to the aFLAPL transfectants (Figure 2) could also
functionally activate the T cells to produce IL2 . To deter-
mine whether the FLpolymers were interacting with theTCR
independent ofMHC Class II molecules, we tested the trans-
fectants for the expression ofMHC Class II gene products
by Northern analysis (Figure 4) . We incubated a series oftrans-
fected cells with the polymer FLtoooDex250o (Table 2) and
PMA for 24 hours as we described earlier (Fig . 3 B) . RNA
was prepared from those cells and from control cell lines such
as Jurkat, 31-13, and a EBV transformed autologous B cell
line (RSEBV) . The RNA was separated on a 1% agarose
gel, and transferred to nitrocellulose, where it was probed
with a combination of threeMHC Class 11 0 cDNAs from
DP,DQ andDR under normal stringency conditions at42°C
(50% formamide and 5x SSC hybridization buffer; 35) . Only
theRNA from the EBV transformed B cells had detectable
MHC Class IImRNA expression (Fig. 4, lane 8), whereas
none ofthe Jurkat derivatives including those which expressed
the COAL TCR had detectable MHC mRNA expression
(Figure 4, lanes 1-7 and 9) . Other Northern blots probed
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Figure 4 . Northern analysis of RNA from
transfected T cells. 30 Icg ofRNA was denatured
and electrophoresed on a 1.5% agarose gel con-
taining MOPS buffer as described in Materials
and Methods. The RNA which was transferred
to nitrocellulose was probed with a mixture of all
three DP, DQ and DR 0 Class II MHC cDNA
probes in equal proportion . The blot was washed
using the same conditions as in Fig. 1 E, and ex-
posed to film for 48 h . RNAs are from cell line
ASA6 (lane 1), E2 (lane 2), Jurkat (lane 3), 1C5
(lane4), 3C11N (lane 5), 31-13 (lane 6), Jurkat (lane
7), RSEBV (lane 8), and 31-13 (lane 9) . RNA
made from cell lines induced for 24 h with
1 Fig/mL FLlooDDEX2500 and PMA is shown in
lanes 1-6, while uninduced cellularRNA is shown
in lanes 6-9.
with eachMHC Class II cDNA separately show an equiva-
lent pattern of expression in the EBV transformed B cells
as well as the Jurkat derivatives (Data not Shown) . All of
theseJurkat derivative cell lines expressMHC Class IRNA
in abundance (Data Not Shown), although Jurkat does not
have any detectable CD8 gene expression (Figure 1 E, lane
8) . These molecular analyses provide strong evidence that the
interaction of the FL antigen with the TCR is independent
of the involvement ofMHC Class II gene products. We pro-
vide further evidence below using a system ofFL substituted
Sepharose beads .
FLSubstituted Sepharose Beads Activate ciFLOFL Transfected T
Cells withoutPMA . It was apparent that in order to develop
a system where the FL antigen directly interacted with T
cells, in the absence of other stimuli or signals, it would be
necessary to eliminate the need for PMA . It was previously
shown that Sepharose 4B beads substituted withFITC could
stimulate the T cell clone RFL 3.8 to secrete IL-2 in the ab-
sence of accessory cells or exogenous IL-2 (27) . We reacted
Sepharose 4B beads with FITC (FL Beads), incubated them
with transfected cell lines for 24 h, and assayed supernatants
for 11,2 . The results are shown in Fig . 5 B . The FL Beads
were fully capable of activating the (XFAL cell line withoutStructure
Fluoriscein Derivatives Conjugated To CNBr Activated Sepharose40
T-' <oit~
d
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Figure 5.
￿
FLderivatives:activation properties on aFLRFL T cell trans-
fectants . (A) Summary of FLderivatives used in the analysis . The com-
pounds shown in (A) were reacted with CNBR Activated Sepharose 4B
with (Spacer) or without previous reaction with 1,6, diaminohexane. In
(C andD) all of the even numbers correspond to 1mM of FL derivitiza-
V-
lion, and the odd numbers to 8mM . In (C) all of the compounds differ
fromFIX in the "bottom" ring, while in (D) the "top" ring is substituted .
(B)The indicated cell lines were mixed with FITC substituted Sepharose
4B beads containing the 1,6 diaminohatane spacer group. Other treat-
ments such as PMA (P), Medium, or FLPolymer+P are for comparison
purpose, andwere done simultaneously with the other treatments. Refer
to Fig. 3 A and Materials and Methods for details of the methods . (C)
The indicated cell lines were treated with derivatized Sepharose4B beads
as shown in (A) . The first series of bars represents results obtained with
ethanolamine-substituted Sepharose 4B beads . (D) same as (C), except that
the last series of bars represent results obtained with cells cultured with
medium (M), or FIjPolymer (FL) .
Chemical Name Spacer
H H
R"N-(CH,)aN-R
Location
FL-0+sothbcyertate Yes Fgwe 4C,2-3
FL-5 "isothiocyenete yes :4-5
5((5-ernnopentyl)thiaxefdYQFL no '"6-7
5((2-entirtoedtyl)thbureidyl)FL no
5((((2-emirtOMryl)thb)aceyi) no
emino)FL
5(amiry)ecetamido)FL no ',+2"+3
5-(4,6-0idtloroViazinyl)anxnoFl yes ',14"15
4'((eminosoetemid0)meNygFL no FigreaD,+sn
tetremetttykhodanAne-S(andS)- yes
isahiooyenete
5,(end"6)oerf)oayneWhoFL yes -.20-2+
suocinimidyl ester
eosin-5-isahiooyenete yes - ',22-23
8n'thrOSin-S-iSOthiOCy3net0 yes 2x-25
rhoddmine-5-(and8)-isothiacyanete yes .2627PMA, and to a level that is comparable to the FLPolymer
and PMA treatment of the same cell line (Fig. 5 B). The
degree of activation in most experiments is dependent on the
concentration of FL on the bead, as exemplified in two sepa-
rate cases where the Sepharose beads are reacted with 8mM
FL derivative, and they are almost twice as effective as those
reacted with 1 mM FL (compare lanes 4 and 6 with S and
7 in Fig. 5 C) . We have also found that FITC-derivatized
APC (an autologous EBVtransformed B cell line) are able
to specifically stimulate UFAL T cell transfectants such as
E3E4, but not control cell lines such as 31-13 or 3C11N (data
not shown). Therefore, the aFL8FL transfectants are able to
recognize FL in the context of an APC, although there is
no mandatory requirement for APC participation in the rec-
ognition complex of TCR+FL.
Fine Specificity ofthe ciFLRFL TCRforFL Derivatives.
￿
We
took advantage of the ability ofFL derivatized Sepharosebeads
to stimulate the aFLOFL transfectants to explore further the
specificity of the TCR for derivatives of FL (Figure 5 A).
We coupled various derivatives of FL to Sepharose directly
using available primary amines, or reacted the isothiocyanate
forms of the FL derivatives to 1,6 diaminohexane substituted
Sepharose (Figure 5 A) . We then treated three different cell
lines with the derivatized beads for 24 hours, and measured
IL-2 in the supernatants usinga CTLL assay. The results are
presented in Figures 5 C and D. We find a remarkable
specificity of the TCR such that the mere alteration of the
"bottom" ring substituent from 5' to the 6' position renders
the compound almost completelyunable to induce T cell ac-
tivation. More radical substitutions to the triple ring oblit-
erate any activity as shown in Figure 5 D. Only FLCad with
its relatively long pentyl group was effective in activation,
although the ethyl form (Figure 5 C, treatment 8, 9) was
ineffective. In an effort to predict the importance of the N-C
= S linkage to activity, we used derivatives which had an
oxygen substituted for the sulphur (Figure 5 C, treatment
10-13). To our surprise both compounds were completely
inert to activation of the aFAL cells. These results show
the exquisite specificity of the TCR for a particular antigen
conformation and structure, and illustrate the complexity
of studying interactions of more complex soluble antigens
with TCRs.
Discussion
Recognition of antigen by T cells has been shown by a
variety of methods to be restricted by the gene products of'
the MHC (see Introduction and reviewed in 44 and 14). It
is generally accepted that a particular antigen is recognized
by T cells only if processed fragments of the antigen bound
to an MHC molecule are recognized by the TCR. Several
studies have addressed the question as to whether a hapten
can interact with TCR without MHC involvement. The
hapten HSAB coupled to polyacrylamide beads was able
directly to stimulate a murine T cell hybridoma, and the re-
sponse could be effectively competed by soluble monomeric
hapten (24) . Other studies showed that the haptens TNP (47)
andp-ABA(23) conjugated to a variety ofproteins were capable
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of binding and activating specific T cell clones. The murine
V~3 gene segment in combination with different V(3 gene
segments was found to be capable of imparting specificity
for p-ABA substituted proteins (48). Finally, in related studies
using a chimeric immunoglobulinTCR protein, it has been
elegantly shown that the haptenic antigen coupled to Sepharose
will activate the transfectant to make IL2 (49).
Although the studies cited aboveindicate that haptens and
hapten-protein conjugates can interact with TCR, the role
of MHC molecules in these interactions has not been fully
clarified. To address this concern, we have analyzed FIrTCR
interactions in a system devoid of the relevant MHC mole-
cules. Several lines of evidence suggest that FL can interact
with the UFLNFL TCR from a CD4+ FIrspecific T cell clone
in a functionally significant manner even in the absence of
Class II MHC gene products. First, UFAL transfectants that
do not express detectable Class II MHC mRNA, bind FL
Polymers in a highly specific manner. Second, in the pres-
ence of PMA, FLPolymers activate a0FL transfectants, but
not other T cells to produce IL2. Cross-linking of TCR is
important in this response, since monomeric FL is incapable
of activation, although it can serve to a limited extent as a
competitive inhibitor ofFLPolymer binding (27 and unpub-
lished results). Third, FL derivatized Sepharose beads acti-
vate the aFLOFL transfectants in a manner that shows exqui-
site antigen specificity (see below) . This effect is mediated
by the interaction of a matrix of FL groups with multiple
TCRs on the T cell. Although physiologic antigen recogni-
tion clearly involves MHC presentation ofprocessed antigen,
our results conclusively demonstrate that hapten specific T
cells can be activated by appropriate antigen-TCR interac-
tions in the complete absence of the relevant class of MHC
molecules.
Although the Jurkat transfectants described here express
classI MHC gene products, a previous analysis with blocking
antibodies indicate that class I molecules expressed by the
T cell have no direct role in FL binding or in subsequent
activation events. Studies with FLspecific T cell clones have
shown that binding of FL polymers is completely unaffected
by the presence of saturating concentrations of anti-class I
antibodies (27). Even in the case of the FLspecific clones RFL
3.45 and RFL 1.65 which are CD8+ and class I restricted,
blocking experiments with the anti-class I antibody W6/32
showed absolutely no inhibitory effect. Thus, class I is not
required for FL binding to the T cell receptor on these cell
lines. This is consistent with the exquisite specificity of FL
binding (Figure 5) . Only FLspecific clones and not other
clones with the same class I MHC genotype bind FL (27).
Furthermore, as shown here, only those transfectants with
an appropriate combination of T cell receptor aand (3 chains
show FL binding even though all express the same comple-
ment of class I MHC molecules (Figure 2). The classI inde-
pendence of the antigen binding of FLspecific T cells is fur-
ther supported by the ability of solubilized RFL 3.8 T cell
receptor molecules to bind to FL columns which do not
significantly bind class I MHC molecules (27).
We have taken advantage of the direct interaction of an-
tigen with TCR to study the fine specificity of the TCRfor derivatives of FL. Our main conclusions are that the
oiFLOF, TCR is sensitive to any alteration of the "top" (triple
ring) or "bottom" (single ring) of the FL structure (Figures
4 A-D). The exchange of the isothiocyanate group from the
5' to the 6' position effectively disables the FL moiety from
being an activator (Figure 5 C, 2-3). Additionally, the sub-
stitution of an amide (N-C-C) for a thiourea (N-C-N) linkage
also eliminates recognition of the compound, with the caveat
that the aminothioacetyl derivative of FL also differs slightly
from the other methylene containing FL compounds in the
spacer region (compare Figure 5 C 4-9 and 10-13). The rela-
tively minor changes in the 5' bottom ring substituent (Figure
5 C,10-11) completely abolishes the activating function. These
data suggest that the single atomic substitution of an ox-
ygen for a sulphur prevents the molecule from serving as an
effective hapten for the UPAL TCR under study.
It was not clear from examining the FL derivatives such
as 5(aminoacetamido)FL and FIrCad Whether the length of
the methylene spacer group (-CH2-) between the Sepharose
bead and the FL moiety was a major factor in the activity
ofthe FL derivative (Figure 5 C compare 4-9). We examined
this issue further by comparing the activities of three FL de-
rivatives that were bound to Sepharose by methylene con-
taining spacer groups. FITC was reacted with diaminohexane
substituted Sepharose resulting in a 6 carbon spacer group,
whereas FISCad was directly reacted with the Sepharose
producing a 5 carbon spacer. Both of these Sepharose deriva-
tives were very active in stimulating the cell line E3E4 to
make IIr2 (Figure 5 C, 4-5, 6-7). However, the 5((2-amino-
ethyl)thioureidyl)FL which contains only a 2 carbon spacer
was not effective as an activating agent (Figure 5 C, 8-9).
The original T cell clone RFL 3.8 was derived by stimula-
tion with FITC derivatized cells on which FL groups were
attached primarily to e amino groups of lysine residues in
membrane proteins. Therefore, it is not surprising that the
TCR recognizes FL beads with 5 and 6 carbon spacers.
We can infer from our results that the arc,OF, TCR makes
multiple contacts with several different atoms of the FITC
molecule. Since FL is a rigid planar molecule there are no
conformational isomers. This may explain how small haptens
tethered to insoluble matrices are able to stimulate T cells,
whereas peptides of sufficient size to contain activating epi-
topes possess too many conformational isomers that are not
recognized by the highly-specific TCR. In fact, the crystal
structure of the MHC Class I molecule (50) which shows
a cleft that could bind peptides helps explain the ability of
MHC-bound peptides to act as T cell activators. The peptide
situated in the MHC cleft may be restricted to a limited
number conformations, and as a result it could be expected
to spend more time in conformations that are recognized by
the TCR. Similarly, the same peptide that is recognized by
a particular T cell in the context of one Class II MHC mole-
cule, generally shows no activity when bound to APC with
a different MHC haplotype. This has been elegantly shown
for specific cytochrome C peptides and Class II MHC mole-
cules in the mouse (12) . Therefore, without MHC involve-
ment, peptides generally are thought to be incapable ofdirectly
stimulating antigen-specific T cells.
One consequence of the requirement for a three way pep-
tide + MHC + TCR interaction is that mutations in any
of the components presumably affect the relationships of all
the components. The FL system may circumventthis problem
by eliminating the need for MHC interactions to obtain rec-
ognition of the haptenic antigen and the TCR. Future studies
ofthis antigen: TCR interaction couldbe conducted on easily
transfectable non T cell hosts (51), and a systematic muta-
genesis of the TCR V« and Vs regions will be carried out
utilizing the ability of the FIrPolymer to directly interact
with the TCR (Buchwalder and Diamond, In Preparation).
Creation of a phosphatidyl-inositol linked form of the
ciFOF, TCR will allow us to prepare a soluble form using
phospholipase C in order to study how the FIJPolymer might
interact with a soluble TCR (51). These studies will lead
to an understanding of how an antigen-specific TCR recog-
nizes its ligand, and which amino acid side chains actually
contact the FL molecule.
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